Search for: "Reckitt Benckiser, Inc."
Results 1 - 20
of 53
Sort by Relevance
|
Sort by Date
19 Feb 2024, 2:15 pm
District Court for the Eastern District of New York, against the drug manufacturers Indivior Inc., Aquestive Therapeutics Inc, Monosol Rx In., and Reckitt Benckiser LLC. [read post]
2 May 2022, 7:48 am
Reckitt Benckiser LLC, No. 20-23564-CIV-COOKE/GOODMAN, 2021 WL 8129371 (S.D. [read post]
11 Jan 2022, 11:45 am
This settlement, with all 50 states and DC, is in addition to a $600 million settlement that Indivior reached with the federal government in 2020, placing third on last year’s list, and the $1.4 billion resolution with Indivior’s former parent, Reckitt Benckiser Group PLC (“RB Group”) which topped the 2019 list of healthcare recoveries. [read post]
11 Jan 2022, 11:45 am
This settlement, with all 50 states and DC, is in addition to a $600 million settlement that Indivior reached with the federal government in 2020, placing third on last year’s list, and the $1.4 billion resolution with Indivior’s former parent, Reckitt Benckiser Group PLC (“RB Group”) which topped the 2019 list of healthcare recoveries. [read post]
31 Jul 2020, 2:11 pm
This is in addition to the $1.4 billion resolution with Indivior’s former parent, Reckitt Benckiser Group PLC (“RB Group”) that was previously announced in 2019. [read post]
6 Apr 2020, 12:30 am
Reckitt Benckiser LLC, the Delaware District Court speculated that the doctrine may be more limited when applied to willful infringement and enhanced damages.[20] The court noted that, if a defendant was willfully blind to a patent covering a product that it copied and then sold, it “could satisfy the knowledge requirement for willful infringement, because the defendant’s willful blindness demonstrates the same level of culpability as if the defendant copied the… [read post]
20 Mar 2020, 4:04 pm
Reckitt Benckiser LLC, 118 USPQ2d 1464 (TTAB 2016) [precedential]. [read post]
27 Jan 2020, 5:26 pm
In another matter, Reckitt Benckiser Group plc paid a total of $1.4 billion to resolve criminal and civil liability related to the marketing of the opioid addiction treatment drug Suboxone, which is a formulation of the opioid buprenorphine. [read post]
24 Jan 2020, 10:24 am
Here are the top ten healthcare recoveries of 2019 by the numbers: Reckitt Benckiser – In July 2019, DOJ, the Federal Trade Commission, and three states (VA, NY, PA) announced a $1.4 billion global settlement of criminal, civil, and administrative claims against Reckitt Benckiser Group PLC and its former subsidiary Indivior Inc. regarding allegations that the defendants engaged in deceptive marketing of Suboxone, a drug used to treat opioid… [read post]
9 Jan 2020, 11:43 am
Reckitt — Multiple whistleblowers received awards from the $700 million Reckitt Benckiser Group plc paid to resolve allegations it violated the False Claims Act relating to its marketing and sale of its opioid addiction treatment drug Suboxone (through its then-subsidiary Indivior Inc.). [read post]
9 Jan 2020, 11:43 am
Reckitt — Multiple whistleblowers received awards from the $700 million Reckitt Benckiser Group plc paid to resolve allegations it violated the False Claims Act relating to its marketing and sale of its opioid addiction treatment drug Suboxone (through its then-subsidiary Indivior Inc.). [read post]
16 Jul 2019, 7:21 am
The National Advertising Division (NAD) affirmed that Reckitt Benckiser, Inc. [read post]
12 Jul 2019, 9:00 am
The first is that probably the four highest profile design cases in the UK in recent years (Procter & Gamble Co v Reckitt Benckiser (UK) Ltd [2007] EWCA Civ 936, Dyson v Vax [2011] EWCA Civ 1206, Samsung Electronics (UK) Ltd v Apple Inc [2012] EWCA Civ 1339, and PMS International Limited v Magmatic Limited [2016] UKSC 12 (i.e. [read post]
11 Jul 2019, 4:47 pm
(then known as Reckitt Benckiser Pharmaceuticals Inc.) marketed and sold Suboxone throughout the United States. [read post]
3 Aug 2018, 11:55 am
Reckitt Benckiser LLC, 118 USPQ2d 1464, 1470 (TTAB 2016). [read post]
26 Feb 2018, 12:27 pm
Reckitt Benckiser has agreed to modify is advertisement to address the NAD’s concerns. [read post]
26 Feb 2018, 12:27 pm
Reckitt Benckiser has agreed to modify is advertisement to address the NAD’s concerns. [read post]
22 Oct 2017, 11:16 am
Stark in Reckitt Benckiser LLC v. [read post]
31 Jul 2017, 9:21 am
NAD Recommends Reckitt Benckiser Discontinue Certain Claims The NAD has recommended that Reckitt Benckiser LLC also discontinue claims that its Amope GelActiv Insoles offer “improved comfort” while wearing high heels. [read post]
31 Jul 2017, 9:21 am
NAD Recommends Reckitt Benckiser Discontinue Certain Claims The NAD has recommended that Reckitt Benckiser LLC also discontinue claims that its Amope GelActiv Insoles offer “improved comfort” while wearing high heels. [read post]
